JF
AZN icon

Jump Financial’s AstraZeneca AZN Stock Holding History

Jump Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,617
Closed -$481K – 1894
2025
Q4 		$481K Sell
2,617
-8,574
-77% -$1.5M 0.01% 1328
2025
Q3 		$1.72M Sell
11,191
-5,548
-33% -$840K 0.02% 786
2025
Q2 		$2.34M Buy
16,739
+15,062
+898% +$2.11M 0.03% 664
2025
Q1 		$246K Sell
1,677
-1,745
-51% -$252K ﹤0.01% 1366
2024
Q4 		$448K Sell
3,422
-573
-14% -$80.2K 0.01% 1131
2024
Q3 		$623K Sell
3,995
-11,781
-75% -$1.9M 0.01% 1015
2024
Q2 		$2.46M Buy
15,776
+8,744
+124% +$1.32M 0.05% 471
2024
Q1 		$953K Buy
+7,032
New +$931K 0.03% 829
2023
Q4 		– Sell
-2,659
Closed -$360K – 1785
2023
Q3 		$360K Buy
+2,659
New +$363K 0.01% 1202
2023
Q1 		– Sell
-2,219
Closed -$301K – 1579
2022
Q4 		$301K Buy
2,219
+81
+4% +$10.2K 0.02% 1044
2022
Q3 		$234K Buy
+2,138
New +$271K 0.01% 1273
2021
Q3 		– Sell
-22,364
Closed -$2.68M – 1098
2021
Q2 		$2.68M Buy
+22,364
New +$2.45M 0.26% 53

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Jump Financial's AZN Position: Q1 2026 in Review

Jump Financial sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 2,617 shares — an estimated $481K sold.

Jump Financial first reported a position in AZN in Q2 2021 and held it in 12 quarters. The position peaked at $2.68M in Q2 2021. 1,385 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Jump Financial reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 2,617 AstraZeneca shares in Q1 2026, an estimated $481K.
  • Jump Financial first reported a position in AstraZeneca in Q2 2021 and held it in 12 quarters.
  • Jump Financial's AstraZeneca position peaked at $2.68M in Q2 2021.
  • 1,385 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.